{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T15:43:35Z","timestamp":1767023015412,"version":"3.48.0"},"posted":{"date-parts":[[2025,12,24]]},"group-title":"Cancer Biology","reference-count":68,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,12,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Loss of the tumor suppressor PTEN is common in T-cell acute lymphoblastic leukemia (T-ALL), and is associated with poor prognosis. PTEN-loss drives robust activation of AKT\/mTORC1 signaling to promote leukemic cell growth. We find that PTEN-loss in T-ALL confers dependence on the guanylate nucleotide synthesis enzyme inosine 5\u2019-monophosphate dehydrogenase (IMPDH) for cell growth and viability. This metabolic vulnerability is dependent on sustained mTORC1 signaling and can be exploited using clinically approved IMPDH inhibitors to selectively kill PTEN-deficient T-ALL cells, and extend survival in genetic and xenograft T-ALL models in mice. Mechanistically, IMPDH inhibitors cause early DNA replication stress, followed by DNA damage. In contrast to treatment with mTORC1 inhibitors, these events culminate in robust and selective cell death in PTEN-deficient T-ALL cells. These findings reveal a targetable metabolic vulnerability in T-ALL, which could provide rationale for repurposing clinically approved IMPDH inhibitors.<\/jats:p>\n                <jats:sec>\n                  <jats:title>Statement of Significance<\/jats:title>\n                  <jats:p>We find that the IMPDH inhibitors mycophenolic acid and mizoribine, which are currently used as well-tolerated immunosuppressants, exert anti-leukemic activity in an aggressive molecular subset of T-ALL cells that are associated with poor prognosis. The use of clinically approved compounds to exploit this vulnerability could lead to rapid drug repurposing.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2025.12.22.696045","type":"posted-content","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T05:25:20Z","timestamp":1766640320000},"source":"Crossref","is-referenced-by-count":0,"title":["PTEN-loss confers dependence on the guanylate synthesis enzyme IMPDH in T-cell acute lymphoblastic leukemia"],"prefix":"10.64898","author":[{"given":"Rayees A.","family":"Padder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thu","family":"Le Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria E. D.","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Chiles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namratha","family":"Sheshadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Mulraney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Xing","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyang","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Herranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander J.","family":"Valvezan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2025122907401304000_2025.12.22.696045v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30031-2"},{"issue":"32","key":"2025122907401304000_2025.12.22.696045v1.2","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1200\/JCO.23.00088","article-title":"Outcome for children and young adults with T-cell ALL and induction failure in contemporary trials","volume":"41","year":"2023","journal-title":"Journal of Clinical Oncology"},{"key":"2025122907401304000_2025.12.22.696045v1.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra052603"},{"issue":"7","key":"2025122907401304000_2025.12.22.696045v1.4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11864-020-00757-5","article-title":"Biology and treatment paradigms in T cell acute lymphoblastic leukemia in older adolescents and adults","volume":"21","year":"2020","journal-title":"Current Treatment Options in Oncology"},{"key":"2025122907401304000_2025.12.22.696045v1.5","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-018-0455-9"},{"key":"2025122907401304000_2025.12.22.696045v1.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1400972"},{"key":"2025122907401304000_2025.12.22.696045v1.7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-018192"},{"key":"2025122907401304000_2025.12.22.696045v1.8","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.580"},{"key":"2025122907401304000_2025.12.22.696045v1.9","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12269"},{"key":"2025122907401304000_2025.12.22.696045v1.10","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3909"},{"issue":"5","key":"2025122907401304000_2025.12.22.696045v1.11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3390\/cancers11050629","article-title":"The Key Roles of PTEN in T-Cell Acute Lymphoblastic Leukemia Development, Progression, and Therapeutic Response","volume":"11","year":"2019","journal-title":"Cancers"},{"key":"2025122907401304000_2025.12.22.696045v1.12","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.146381"},{"key":"2025122907401304000_2025.12.22.696045v1.13","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.059030"},{"key":"2025122907401304000_2025.12.22.696045v1.14","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.209"},{"key":"2025122907401304000_2025.12.22.696045v1.15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-206722"},{"key":"2025122907401304000_2025.12.22.696045v1.16","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07807-0"},{"key":"2025122907401304000_2025.12.22.696045v1.17","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.462"},{"key":"2025122907401304000_2025.12.22.696045v1.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01159-z"},{"key":"2025122907401304000_2025.12.22.696045v1.19","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0216-7"},{"key":"2025122907401304000_2025.12.22.696045v1.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.04.001"},{"key":"2025122907401304000_2025.12.22.696045v1.21","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-019-0038-7"},{"key":"2025122907401304000_2025.12.22.696045v1.22","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041543"},{"key":"2025122907401304000_2025.12.22.696045v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0199-y"},{"key":"2025122907401304000_2025.12.22.696045v1.24","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.352"},{"issue":"5","key":"2025122907401304000_2025.12.22.696045v1.25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.trecan.2016.03.008","article-title":"Emerging role of mTOR in the response to cancer therapeutics","volume":"2","year":"2016","journal-title":"Trends in cancer"},{"key":"2025122907401304000_2025.12.22.696045v1.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063564"},{"key":"2025122907401304000_2025.12.22.696045v1.27","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20784"},{"key":"2025122907401304000_2025.12.22.696045v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.09.013"},{"key":"2025122907401304000_2025.12.22.696045v1.29","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.135071"},{"key":"2025122907401304000_2025.12.22.696045v1.30","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0489"},{"key":"2025122907401304000_2025.12.22.696045v1.31","doi-asserted-by":"publisher","DOI":"10.1126\/science.1228792"},{"key":"2025122907401304000_2025.12.22.696045v1.32","doi-asserted-by":"publisher","DOI":"10.1126\/science.1228771"},{"key":"2025122907401304000_2025.12.22.696045v1.33","doi-asserted-by":"publisher","DOI":"10.2174\/092986730607220401123549"},{"key":"2025122907401304000_2025.12.22.696045v1.34","doi-asserted-by":"publisher","DOI":"10.5500\/wjt.v2.i4.51"},{"key":"2025122907401304000_2025.12.22.696045v1.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.06.005"},{"key":"2025122907401304000_2025.12.22.696045v1.36","doi-asserted-by":"publisher","DOI":"10.1172\/jci139929"},{"issue":"9","key":"2025122907401304000_2025.12.22.696045v1.37","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/hep4.1559","article-title":"Targeted inhibition of purine metabolism is effective in suppressing hepatocellular carcinoma progression","volume":"4","year":"2020","journal-title":"Hepatology communications"},{"key":"2025122907401304000_2025.12.22.696045v1.38","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000002647"},{"key":"2025122907401304000_2025.12.22.696045v1.39","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24416"},{"key":"2025122907401304000_2025.12.22.696045v1.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-019-0363-9"},{"key":"2025122907401304000_2025.12.22.696045v1.41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17512-x"},{"key":"2025122907401304000_2025.12.22.696045v1.42","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08224-z"},{"key":"2025122907401304000_2025.12.22.696045v1.43","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(83)90301-5"},{"key":"2025122907401304000_2025.12.22.696045v1.44","doi-asserted-by":"publisher","DOI":"10.1021\/bi0271401"},{"key":"2025122907401304000_2025.12.22.696045v1.45","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv047"},{"issue":"7","key":"2025122907401304000_2025.12.22.696045v1.46","first-page":"285","article-title":"The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K\/Akt pathway in Jurkat T cells","volume":"13","year":"2002","journal-title":"Cell Growth Differ"},{"key":"2025122907401304000_2025.12.22.696045v1.47","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c01658"},{"key":"2025122907401304000_2025.12.22.696045v1.48","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2897"},{"key":"2025122907401304000_2025.12.22.696045v1.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2014.08.004"},{"key":"2025122907401304000_2025.12.22.696045v1.50","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2672"},{"key":"2025122907401304000_2025.12.22.696045v1.51","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209883"},{"key":"2025122907401304000_2025.12.22.696045v1.52","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3955"},{"key":"2025122907401304000_2025.12.22.696045v1.53","doi-asserted-by":"publisher","DOI":"10.1126\/science.1102160"},{"key":"2025122907401304000_2025.12.22.696045v1.54","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0095"},{"key":"2025122907401304000_2025.12.22.696045v1.55","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088"},{"key":"2025122907401304000_2025.12.22.696045v1.56","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-23-0816"},{"key":"2025122907401304000_2025.12.22.696045v1.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2004.08.026"},{"key":"2025122907401304000_2025.12.22.696045v1.58","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200403069"},{"key":"2025122907401304000_2025.12.22.696045v1.59","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2014.00108"},{"key":"2025122907401304000_2025.12.22.696045v1.60","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01350-5"},{"key":"2025122907401304000_2025.12.22.696045v1.61","doi-asserted-by":"publisher","DOI":"10.2174\/092986730607220401123549"},{"key":"2025122907401304000_2025.12.22.696045v1.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2014.01.014"},{"issue":"21","key":"2025122907401304000_2025.12.22.696045v1.63","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.3760\/cma.j.issn.0366-6999.20140627","article-title":"Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis","volume":"127","year":"2014","journal-title":"Chinese medical journal"},{"key":"2025122907401304000_2025.12.22.696045v1.64","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13997"},{"issue":"3","key":"2025122907401304000_2025.12.22.696045v1.65","first-page":"547","article-title":"Impact of UGT1A9 Polymorphism on Mycophenolic Acid Pharmacokinetic Parameters in Stable Renal Transplant Patients","volume":"12","year":"2013","journal-title":"Iran J Pharm Res"},{"key":"2025122907401304000_2025.12.22.696045v1.66","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008955"},{"key":"2025122907401304000_2025.12.22.696045v1.67","doi-asserted-by":"publisher","DOI":"10.1021\/ac070470c"},{"key":"2025122907401304000_2025.12.22.696045v1.68","doi-asserted-by":"publisher","DOI":"10.1021\/ac1021166"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2025.12.22.696045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T15:40:20Z","timestamp":1767022820000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2025.12.22.696045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":68,"URL":"https:\/\/doi.org\/10.64898\/2025.12.22.696045","relation":{},"subject":[],"published":{"date-parts":[[2025,12,24]]},"subtype":"preprint"}}